However, since levels of type I IFN and ISGs were not measured in COPG1 (K652E) patients and the clinical presentation does not overlap with symptoms of COPA syndrome, no conclusion about contribution of a STING-driven pathology can be drawn. This evidence concerns the gene STING1 and autoimmune interstitial lung disease-arthritis syndrome.